# Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System

> **NCT05672875** · — · TERMINATED · sponsor: **SRI International** · enrollment: 343 (actual)

## Conditions studied

- Anthrax

## Interventions

- **DIAGNOSTIC_TEST:** Anthrax LF Dx System

## Key facts

- **NCT ID:** NCT05672875
- **Lead sponsor:** SRI International
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-01-23
- **Primary completion:** 2023-04-20
- **Final completion:** 2023-04-20
- **Target enrollment:** 343 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05672875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05672875, "Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05672875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*